HCG Cancer Centre Bengaluru is proud to announce the launch of the CyberKnife S7 System, a fully automated, AI-driven treatment delivery system with real-time motion adaptation, marking a significant advancement in the treatment of both cancerous and non-cancerous tumors. The system was unveiled by Dr.
Revenue for Q1 FY25 of INR 5,256 million, a growth of 14% (y-o-y) EBITDA for Q1 FY25 of INR 929 million, a growth of 21% (y-o-y) and PAT for Q1 FY25 of INR 121 million, a growth of 59% (y-o-y) HealthCare Global Enterprises Limited (“HCG”), the leader
Revenue for Q4 FY24 of INR 4,946 Million, a growth of 12% (y-o-y) and for FY24 of INR 19,121 Million, a growth of 13% (y-o-y) EBITDA for Q4 FY24 of INR 941 Million, a growth of 21% (y-o-y) and EBITDA for FY24 of INR 3,374 Million,
Rajasthan government working on developing population-based cancer registry Ms Shubhra Singh, Additional Chief Secretary, Medical & Health and Family Welfare Department, Govt of Rajasthan today said that Rajasthan government is dedicated towards “swasthya” with 7.4% of public spend on healthcare. While applauding FICCI for taking up
~Strategically located near fast growing prime residential neighborhoods, the two new facilities at Whitefield and North Bengaluru will offer patients the complete range of advanced cancer care~ Healthcare Global Enterprises Limited (HCG) is expanding its footprint in Bengaluru with the launch of its two new state of
Those seeking cancer care and information have seamless access to their doctors, expert treatment, and medicines at all times~ HealthCare Global Enterprises Ltd., the largest cancer care network in India has launched the HCG Care app, the first of its kind in the oncology care space.
HCG Abdur Razzaque Ansari Cancer Hospital Ranchi announced the launch of Jharkhand’s most advanced Elekta Versa HD Platform, a versatile, all-in-one system that is capable of delivering a wide variety of external radiation therapy modalities for a broad spectrum of cancers. The media was briefed by
HealthCare Global Enterprises Limited (HCG), largest cancer care network in India, becomes mercury-free hospital by eliminating mercury-based medical measuring devices to promote more stringent medical hygiene and eco-friendly practices. HCG phased out mercury-based instruments such as thermometers, sphygmomanometers, blood pressure monitoring devices, gastrointestinal devices, calibrators,
Revenue for Q2 FY22 of INR 4,200 Million, a growth of 19.3% (y-o-y) and 2.9% (q-o-q) Revenue for H1 FY23 of INR 8281 Million, a growth of 22.7% (y-o-y) EBITDA for Q2 FY23 of INR 810 Million, a growth of 28.0% (y-o-y) and 7.2% (q-o-q) EBITDA for
To provide patients access to world-class treatment facilities and with a commitment to offering high-quality clinical care, HCG Cancer Hospital, Bengaluru, one of India’s largest dedicated cancer care Hospitals announced the launch of India’s first Varian Ethos™ therapy, an Artificial Intelligence (AI)-driven holistic solution designed
